Efficacy of a slow-release formulation of lanreotide (Autogel® 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): An open, multicentre longitudinal study

C. L. Ronchi, M. Boschetti, E. C Degli Uberti, S. Mariotti, S. Grottoli, P. Loli, G. Lombardi, G. Tamburrano, M. Arvigo, G. Angeletti, P. F. Boscani, P. Beck-Peccoz, M. Arosio

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy of a slow-release formulation of lanreotide (Autogel® 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): An open, multicentre longitudinal study'. Together they form a unique fingerprint.

Medicine & Life Sciences